RE:RE:RE:ASCO 2024 - Trial in Progress abstracts Good find on ONCY's biomarker presentation at ASCO 2024. - at a time in preparation for ONCY's acquisition and pelareorep's subsequent accelerated approval
Authors: Richard Trauger, Houra Loghmani, Amy Kupic, Thomas Heineman